KRAS, BRAF and PIK3CA Status in Squamous Cell Anal Carcinoma (SCAC)

Anti-EGFR therapy appears to be a potential treatment option for squamous cell anal carcinoma (SCAC). KRAS mutation is a rare event in SCAC, indicating the absence of the principal mechanism of resistance to this type of therapy. However, no information is available from the literature regarding the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Casadei Gardini, Andrea, Capelli, Laura, Ulivi, Paola, Giannini, Massimo, Freier, Eva, Tamberi, Stefano, Scarpi, Emanuela, Passardi, Alassandro, Zoli, Wainer, Ragazzini, Angela, Amadori, Dino, Frassineti, Giovanni Luca
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3958420/
https://ncbi.nlm.nih.gov/pubmed/24642661
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0092071
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados